We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig... Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells. Show more
β Top-line Phase 1 CSU results expected at year end 2024 β SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK006 for the...
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the βCompanyβ) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and...
SAN CARLOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the βCompanyβ) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -6.76691729323 | 1.33 | 1.47 | 1.18 | 606669 | 1.33186948 | CS |
4 | 0.09 | 7.82608695652 | 1.15 | 1.51 | 1.11 | 507717 | 1.31899933 | CS |
12 | -0.12 | -8.82352941176 | 1.36 | 1.51 | 0.9799 | 492167 | 1.25271869 | CS |
26 | -0.94 | -43.119266055 | 2.18 | 3.405 | 0.9799 | 1120988 | 1.64187303 | CS |
52 | -3.51 | -73.8947368421 | 4.75 | 5.64 | 0.9799 | 1048613 | 2.41313927 | CS |
156 | -100.52 | -98.7814465409 | 101.76 | 112.87 | 0.9799 | 1320578 | 9.0185677 | CS |
260 | -37.93 | -96.8343119734 | 39.17 | 157.98 | 0.9799 | 926908 | 20.48117798 | CS |
Symbol | Price | Vol. |
---|---|---|
NVOSNovo Integrated Sciences Inc | $ 1.05 (132.82%) | 310.28M |
GWAVGreenwave Technology Solutions Inc | $ 0.0387 (-7.86%) | 305.13M |
FFIEFaraday Future Intelligent Electric Inc | $ 0.584899 (3.47%) | 223.84M |
SQQQProShares UltraPro Short QQQ | $ 10.02 (0.00%) | 161.89M |
CRKNCrown Electrokinetics Corporation | $ 0.0998 (-12.07%) | 155.13M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions